Patents by Inventor Shohei Miyamoto

Shohei Miyamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200231941
    Abstract: A gene-modified coxsackievirus that is to be used in oncolytic virotherapy and is improved in safety and/or aggressiveness is provided. A gene-modified coxsackievirus that contains a mutated genome with a coxsackievirus B3 wild-type (CVB3-WT) genome inserted with at least one polynucleotide constituted of a target sequence for at least one of either of miR-34a and miR-34c and is suppressed in proliferation in normal cells is provided.
    Type: Application
    Filed: April 18, 2018
    Publication date: July 23, 2020
    Inventors: Yang JIA, Shohei MIYAMOTO, Kenichiro HARA, Atsuhumi IWANAGA, Kenzaburo TANI
  • Publication number: 20200033006
    Abstract: A combustor nozzle includes a nozzle main body extending along an axis. The nozzle main body includes a first fuel passage which is formed along the axis and through which first fuel flows, a first fuel ejection passage which extends to an outer circumferential surface of the nozzle main body toward a distal end side thereof from the first fuel passage and ejects the first fuel from the outer circumferential surface, an air flow passage which extends in an axial direction on a radial outer side of the first fuel passage with respect to the axis and through which purge air flows, and an air ejection passage which extends from the air flow passage toward a center of a distal end of the nozzle main body and ejects the purge air from the center of the distal end.
    Type: Application
    Filed: March 12, 2018
    Publication date: January 30, 2020
    Inventors: Kenji MIYAMOTO, Kenta TANIGUCHI, Kei INOUE, Shohei DOMEN, Yuichi ICHIKAWA, Satoshi TANIMURA
  • Patent number: 10510460
    Abstract: A method of manufacturing a laminate, transistor, and method of manufacturing transistor using a composition that includes an organic compound having a hydroxy group; a first cross-linking agent that is at least one organic silicon compound selected from the group including an organic silicon compound including a siloxane bond in the molecule and having three or more cyclic ether groups in the molecule, a chain organic silicon compound including two or more siloxane bonds in the molecule and having two or more cyclic ether groups in the molecule, a cyclic organic silicon compound including D unit in the molecule and having four or more cyclic ether groups bonded to a silicon atom of the D unit in the molecule, and a cyclic organic silicon compound including a T unit in the molecule and having two or more cyclic ether groups in the molecule; and a photocationic polymerization initiator.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: December 17, 2019
    Assignee: NIKON CORPORATION
    Inventors: Shohei Koizumi, Takashi Sugizaki, Kenji Miyamoto, Yusuke Kawakami
  • Patent number: 10476005
    Abstract: Laminate, method of manufacturing laminate, transistor, and method of manufacturing transistor using a composition having the following (a) to (c): (a) a first organic compound represented by Formula (1) below (R represents a hydrogen atom or a glycidyl group.
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: November 12, 2019
    Assignee: NIKON CORPORATION
    Inventors: Shohei Koizumi, Takashi Sugizaki, Kenji Miyamoto, Yusuke Kawakami
  • Patent number: 10076547
    Abstract: A modified coxsackievirus showing improved safety and/or aggressiveness to be used for oncolytic virotherapy is provided. A modified coxsackievirus showing tissue-specific suppression of proliferation and comprising a mutated genome consisting of the genome of coxsackievirus B3 wild-type (CVB3-WT) inserted with at least one polynucleotide consisting of a target sequence of tissue-specific microRNA (miRNA) is provided. The mutated genome is preferably further inserted with the region encoding GM-CSF in an expressible form.
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: September 18, 2018
    Assignees: SHIN NIHON SEIYAKU CO., LTD, KYUSHU UNIVERSITY NATIONAL UNIVERSITY CORPORATION
    Inventors: Kenzaburo Tani, Shohei Miyamoto, Hiroyuki Inoue, Miyako Sagara
  • Patent number: 9566307
    Abstract: A pharmaceutical composition contains a coxsackievirus A11 type that infects cancer cells or an echovirus 4 type that infects cancer cells. The coxsackievirus A11 type and the echovirus 4 type may have capsid eliminated. The pharmaceutical composition has an intensive cytotoxicity to a cell of cancer selected from the group consisting of small cell lung cancer, non-small cell lung cancer, lung squamous cell carcinoma, malignant mesothelioma, colorectal cancer, colon/rectum cancer, esophageal cancer, hypopharynx cancer, human-B-lymphocyte tumor, breast cancer, cervical cancer, and pancreatic cancer, which is the cancer cells of a solid cancer.
    Type: Grant
    Filed: April 19, 2013
    Date of Patent: February 14, 2017
    Assignee: KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
    Inventors: Kenzaburo Tani, Hiroyuki Inoue, Keisuke Yasunari, Shohei Miyamoto
  • Publication number: 20160143969
    Abstract: A modified coxsackievirus showing improved safety and/or aggressiveness to be used for oncolytic virotherapy is provided. A modified coxsackievirus showing tissue-specific suppression of proliferation and comprising a imitated genome consisting of the genome of coxsackievirus B3 wild-type (CVB3-WT) inserted with at least one polynucleotide consisting of a target sequence of tissue-specific microR NA (miRNA) is provided. The mutated genome is preferably further inserted with the region encoding GM-CSF in an expressible form.
    Type: Application
    Filed: April 17, 2014
    Publication date: May 26, 2016
    Applicant: KYUSHU UNIVERSITY NATIONAL UNIVERSITY CORPORATION
    Inventors: Kenzaburo Tani, Shohei Miyamoto, Hiroyuki Inoue, Miyako Sagara
  • Publication number: 20150297650
    Abstract: A pharmaceutical composition contains a coxsackievirus A11 type that infects cancer cells or an echovirus 4 type that infects cancer cells. The coxsackievirus A11 type and the echovirus 4 type may have capsid eliminated. The pharmaceutical composition has an intensive cytotoxicity to a cell of cancer selected from the group consisting of small cell lung cancer, non-small cell lung cancer, lung squamous cell carcinoma, malignant mesothelioma, colorectal cancer, colon/rectum caner, esophageal cancer, hypopharynx cancer, human-B-lymphocyte tumor, breast cancer, cervical cancer, and pancreatic cancer, which is the cancer cells of a solid cancer.
    Type: Application
    Filed: April 19, 2013
    Publication date: October 22, 2015
    Inventors: Kenzaburo Tani, Hiroyuki Inoue, Keisuke Yasunari, Shohei Miyamoto